 Home > Biochemistry News > Biotechnology News > Takeda Announces Collaboration to Develop Reproducible, Non-Viral Gene Therapies

Takeda Announces Collaboration to Develop Reproducible, Non-Viral Gene Therapies

 Last Update: 2022-05-23
 Source: Internet
 Author: User

Tags

drive design

design masonry

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On February 23, Takeda and Code Biotherapeutics (Code Bio) jointly announced a collaboration and option agreement whereby Takeda will utilize Code Bio's proprietary 3DNA-targeted non-viral gene drug delivery platform to design and develop treatments for rare diseases Indications for gene therapy

Through the agreement, Takeda and Code Bio will design and develop a targeted gene therapy utilizing Code Bio's 3DNA platform for a rare disease program in the liver, plus additional research in a rare disease program in the central nervous system

Code Bio's targeted 3DNA non-viral gene drug delivery platform is designed to overcome key limitations of other gene drug delivery routes and fully unlock the potential of gene drugs

References:

[1] Code Biotherapeutics Announces Collaboration with Takeda to Use Proprietary 3DNA Genetic Medicine Delivery Platform to Design and Develop Gene Therapies for Rare Diseases.

(Original abridged)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.